Polskie Towarzystwo Ginekologii Onkologicznej

What Polskie Towarzystwo Ginekologii Onkologicznej does

Polskie Towarzystwo Ginekologii Onkologicznej (PTGO) is a Polish registered non-profit professional medical society founded in 1991 and headquartered in Warsaw (ul. Promyka 13). It serves as the official credentialing and standard-setting body for gynecologic oncology in Poland, administering board certification examinations, publishing clinical guidelines (cervical, endometrial, and ovarian cancer), and organizing continuing medical education through webinars, the VII Kongres PTGO, and the Akademia Ginekologii Onkologicznej (AGO) educational portal.

The society operates a portfolio of programs: AGO for educational content delivery; PGOG (Polska Grupa Onkologii Ginekologicznej ds. Badań Klinicznych) for clinical trial coordination; KMGO (Klub Młodych Ginekologów Onkologów) for members under 40; the Koalicja Diagnostyczno-Kliniczna (KDK) for diagnostic pathways; and OVA_GEN+, a GSK-sponsored genomic profiling program providing FoundationOne CDx testing to advanced ovarian cancer patients. A 16-member regional consultant network and the National Consultant in Gynecologic Oncology provide state-level clinical authority.

PTGO is funded through annual membership fees (200 PLN per member, due end of Q1), conference and event registration fees, and pharmaceutical/industry partnerships (GSK, AstraZeneca) for educational programs and research. Day-to-day administration is handled by MedicalArt Group Sp. z o.o. under a secretariat arrangement. The 2025–2029 Board comprises 15 members led by President Dr Radosław Mądry, with Prof. Anita Chudecka-Głaz as President-Elect.

Name

Polskie Towarzystwo Ginekologii Onkologicznej

Legal name

Polskie Towarzystwo Ginekologii Onkologicznej

Website

https://ptgo.pl

Company type

Private

Founded year

1991

Operating status

Operating

Short description

Polish professional medical society (founded 1991, Warsaw) that serves as the official credentialing and standard-setting body for gynecologic oncology in Poland, providing physician certification, clinical guidelines, continuing education, and the OVA_GEN+ genomic profiling program.

Ownership category

akta.pro rank

Product category

Professional Medical Society Services

NAICS

Professional, Scientific, and Technical Services (541)

SIC

Services-Health Services (8000), Services-Misc Health & Allied Services, Nec (8090)

akta.pro industry

PRIMARYHLAKAFAF

Gynecologic Oncology

Healthcare & Life Sciences/Specialist Medical Practice/Hematology & Oncology

Keywords

• Gynecologic oncology education
• Clinical practice guidelines
• Medical society membership
• Professional certification
• Continuing medical education

Headquarters

HQ city

Warszawa

HQ country

Poland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Membership subscriptions: Annual membership fees constitute a core revenue stream. The annual fee is 200 PLN per member, collected by the end of Q1 each year. Members receive benefits including discounted conference registration, access to educational materials, online webinars, and certification.
2. Conference and event registration fees: Revenue generated from scientific congresses, conferences, workshops, and webinars organized by PTGO. Members benefit from reduced registration fees compared to non-members.
3. Pharmaceutical and healthcare industry partnerships: PTGO collaborates with pharmaceutical companies (GSK, AstraZeneca, and others) on educational programs, clinical guidelines, and research projects such as OVA_GEN+. These partnerships provide funding for educational initiatives and scientific activities.
4. Sponsorships and patronage fees: Third-party organizations pay patronage fees and sponsorship contributions for PTGO-associated educational events and scientific programs, in accordance with the society's patronage regulations.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels8 records

Core offering

Polskie Towarzystwo Ginekologii Onkologicznej (PTGO) is a non-profit professional medical society that provides gynecologic oncologists in Poland with annual membership, board certification examinations, evidence-based clinical guidelines, continuing medical education through the AGO educational portal and webinars, and scientific congresses. The society also administers patient-facing programs such as OVA_GEN+ for free genomic profiling of advanced ovarian cancer patients and operates sub-organizations for young specialists (KMGO) and clinical research (PGOG). Its offerings are directed at individual medical professionals, healthcare institutions, and pharmaceutical partners across Poland.

Product overview

PTGO operates as a professional medical society offering a portfolio of educational portals, clinical programs, and professional development resources. The core offering includes Akademia Ginekologii Onkologicznej (AGO) as the primary educational portal, OVA_GEN+ for comprehensive genomic profiling of ovarian cancer patients, and professional sub-organizations such as KMGO for young oncologists and PGOG for clinical research. Supporting initiatives include the Koalicja Diagnostyczno-Kliniczna (KDK) for diagnostic-therapeutic pathways and clinical guidelines published by the society.

Differentiator

Problem solved

Functional benefit

Brands

• Akademia Ginekologii Onkologicznej (AGO): Educational portal affiliated with PTGO providing the latest educational materials, scientific news, workshops, and conference reports on gynecological oncology.
• Polska Grupa Onkologii Ginekologicznej ds. Badań Klinicznych (PGOG)
• Klub Młodych Ginekologów Onkologów (KMGO)

Products and services

• Annual PTGO Membership
• Gynecologic Oncology Board Certification Examination
• VII Kongres PTGO (Scientific Congress)
• Continuing Medical Education Webinars
• OVA_GEN+ Genomic Profiling Program
• PTGO Clinical Recommendations and Guidelines
• ESGO Membership via PTGO Preferential Rate

Quantifiable outcome

• 14 new board-certified gynecologic oncologists per examination cycle
• +2 more outcomes

Named customers5 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Eleven partnerships are on record, tiered core, major and minor.

• European Society of Gynaecological Oncology (ESGO)coreStrategic or Co-development PartnerPTGO maintains a formal membership partnership with ESGO, facilitating knowledge exchange, joint congress participation, and preferential ESGO membership rates for PTGO members (160.00 EUR negotiated rate). PTGO is ESGO's primary Polish national society counterpart and collaborates on guideline development and clinical standards.
• European Society of Medical Oncology (ESMO)coreStrategic or Co-development PartnerPTGO members hold memberships in ESMO, and the society's educational content and guidelines are aligned with ESMO clinical standards. Joint educational webinars and conference participation strengthen the relationship.
• GSK (GlaxoSmithKline)coreGTM or Marketing PartnerPTGO partnered with GSK to launch the OVA_GEN+ program, providing free comprehensive genomic profiling (FoundationOne CDx) for newly diagnosed advanced ovarian cancer patients. This is an educational-scientific-health project led by PTGO with GSK's support, enabling precision oncology access for Polish patients.
• MedicalArt Group Sp. z o.o.coreImplementation/ SI/ Consulting PartnerMedicalArt Group serves as PTGO's secretariat, managing day-to-day operations including membership administration, event logistics, financial management, and data processing. Located at ul. Promyka 13, Warsaw.
• Koalicja Diagnostyczno-Kliniczna (KDK)majorStrategic or Co-development PartnerPTGO is a partner in the Koalicja Diagnostyczno-Kliniczna (Diagnostic-Clinical Coalition), which provides diagnostic pathways for ovarian cancer and endometrial cancer, treatment algorithms, and educational materials. The coalition is promoted on PTGO's website.
• RakMisja (Stowarzyszenie Kobiet Onkologii Polskiej)minorGTM or Marketing PartnerRakMisja (Polish Association of Women's Oncology) is a partner in PTGO's educational and patient awareness initiatives. Dr Anna Dańska-Bidzińska serves as President of RakMisja, linking the two organizations.
• Polish Chamber of Physicians and Dentists (Nil)minorOthersPTGO collaborates with NIL on matters related to physician certification, professional standards, and HPV vaccination advocacy in schools.
• Polskie Towarzystwo Ginekologów i Położników (PTGiP)majorStrategic or Co-development PartnerPTGO works closely with PTGiP (Polish Society of Gynecologists and Obstetricians) on shared clinical guidelines, surgical standards, HPV vaccination advocacy, and screening program alignment. Multiple board members hold dual memberships in both societies.
• AstraZenecamajorGTM or Marketing PartnerAstraZeneca co-sponsored the webinar series 'Przełomy w terapii raka jajnika i raka endometrium' (Breakthroughs in Ovarian and Endometrial Cancer Therapy) with PTGO, providing educational content on drug program updates and clinical trial data.
• Polska Grupa Onkologii Ginekologicznej ds. Badań Klinicznych (PGOG)coreStrategic or Co-development PartnerPGOG is an organizational unit within PTGO dedicated to clinical trials in gynecologic oncology. Its chairperson (Prof. Lubomir Bodnar) serves on PTGO's Board. PGOG has a dedicated sub-account within PTGO's bank account and conducts multi-center clinical research.
• National Consultant in Gynecologic OncologycoreOthersThe National Consultant in Gynecologic Oncology (currently Prof. Mariusz Bidziński, appointed March 26, 2026 for a 5-year term) provides official state-level clinical guidance and is a key counterpart for the Polish Ministry of Health and NFZ. The National Consultant participates in PTGO Board meetings with advisory voice.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Emerging players

• International Gynecologic Cancer Society (IGCS): International society advancing gynecologic cancer research, education, and care. PTGO's PGOG and AGO portal serve analogous functions within Poland, while IGCS operates at global scope, making it a directly comparable professional society peer.
• European Society of Gynaecological Oncology (ESGO): Pan-European specialty society in gynecologic oncology with which PTGO holds a formal membership partnership and preferential-rate arrangement. Directly comparable in mission (guidelines, certification, congresses) but operates at continental rather than national scope.

Direct peers

• Society of Gynecologic Oncology (SGO): U.S. national professional society dedicated exclusively to gynecologic oncology. Mirrors PTGO's role as the certifying and standard-setting body for gynecologic oncologists in its country, with comparable guideline publication, annual meeting, and member-driven advocacy model.
• Polskie Towarzystwo Ginekologów i Położników (PTGiP): Polish sister society for obstetrics and gynecology broadly, collaborating with PTGO on shared guidelines, HPV advocacy, and surgical standards. Multiple PTGO board members hold dual membership, making it a directly comparable domestic professional society peer.

Regional players

• British Gynaecological Cancer Society (BGCS): UK national society for gynecological cancer specialists providing training, guidelines, and annual scientific meetings. Directly comparable to PTGO in scope and activities, though serving the UK rather than Poland.
• Sociedad Española de Ginecología y Obstetricia (SEGO): Spanish national OB-GYN society with comparable functions to PTGiP and PTGO combined. Provides specialty training, guidelines, and congress activities, but at Spanish OB-GYN-broad scope rather than gynecologic oncology specialty alone.
• Société Française d'Oncologie Gynécologique (SFOG): French national society in gynecologic oncology operating with comparable functions (clinical recommendations, training, scientific meetings) but in a different national setting. The French CSO/FRHMG structures are directly analogous to PTGO's PGOG and AGO portals.
• Arbeitsgemeinschaft Gynäkologische Onkologie (AGO Germany): German working group on gynecologic oncology whose mission (clinical guidelines, ovarian/endometrial/cervical cancer recommendations, interdisciplinary cooperation) directly mirrors PTGO's. Functions as the equivalent German national specialty body, but in a different geography.

Broad incumbents

• American Society of Clinical Oncology (ASCO): Large U.S. clinical oncology society offering overlapping education and guideline functionality to PTGO. ASCO's broader portfolio (all oncology subspecialties) makes it an incumbent peer rather than a direct competitor in the gynecologic oncology niche.
• European Society for Medical Oncology (ESMO): European clinical oncology society for all oncology subspecialties with which PTGO members hold dual memberships. Serves as the broader European counterpart where ESGO is the direct gynecologic oncology channel.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles15 records

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Polskie Towarzystwo Ginekologii Onkologicznej